Commentary

Biotechs shift priorities amidst financing challenges

Read more

Commentary: FDA guides industry on psychedelic drugs

Read more

Commentary: The analysis of biopharma R&D needs to be improved

Read more

How creative incubation supports life science in UK

Read more

Climate change is transforming infectious disease

Read more

The lasting value of small molecule drugs

Read more

Investigating a functional cure for hepatitis B

Read more

Therapeutic approaches to geographic atrophy

Read more

A cell therapy approach for hearing loss

Read more

The quest for big data

Read more